1 | CDCA7, DNMT3B, HELLS, ICF1, ICF2, ICF3, ICF4, ZBTB24
|
| CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome.
|
| Unoki M, Funabiki H, Velasco G, Francastel C, Sasaki H.
|
| J Clin Invest 129(1):78-92. doi: 10.1172/JCI99751. Epub 2018 Nov 19.
2019
|
2 | CDCA7, DNMT3B, HELLS, ICF1, ICF2, ICF3, ICF4, ZBTB24
|
| Three Types of Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome Identified by Whole-Exome Sequencing in Saudi Hypogammaglobulinemia Patients: Clinical, Molecular, and Cytogenetic Features.
|
| Alghamdi HA, Tashkandi SA, Alidrissi EM, Aledielah RD, AlSaidi KA, Alharbi ES, Habazi MK, Alzahrani MS.
|
| J Clin Immunol 38(8):847-853. doi: 10.1007/s10875-018-0569-9. Epub 2018 Dec 3. No abstract available.
2018
|
3 | CDCA7, HELLS, ICF2, ICF3, ICF4, ZBTB24
|
| Comparative methylome analysis of ICF patients identifies heterochromatin loci that require ZBTB24, CDCA7 and HELLS for their methylated state.
|
| Velasco G, Grillo G, Touleimat N, Ferry L, Ivkovic I, Ribierre F, Deleuze JF, Chantalat S, Picard C, Francastel C.
|
| Hum Mol Genet 27(14):2409-2424. doi: 10.1093/hmg/ddy130.
2018
|
4 | CDCA7, HELLS
|
| HELLS and CDCA7 comprise a bipartite nucleosome remodeling complex defective in ICF syndrome.
|
| Jenness C, Giunta S, Müller MM, Kimura H, Muir TW, Funabiki H.
|
| Proc Natl Acad Sci U S A 115(5):E876-E885. doi: 10.1073/pnas.1717509115. Epub 2018 Jan 16.
2018
|
5 | CDCA7, ZBTB24
|
| Converging disease genes in ICF syndrome: ZBTB24 controls expression of CDCA7 in mammals.
|
| Wu H, Thijssen PE, de Klerk E, Vonk KK, Wang J, den Hamer B, Aytekin C, van der Maarel SM, Daxinger L.
|
| Hum Mol Genet 25(18):4041-4051. doi: 10.1093/hmg/ddw243. Epub 2016 Jul 27.
2016
|
6 | CDCA7, HELLS, ICF3, ICF4
|
| Mutations in CDCA7 and HELLS cause immunodeficiency-centromeric instability-facial anomalies syndrome.
|
| Thijssen PE, Ito Y, Grillo G, Wang J, Velasco G, Nitta H, Unoki M, Yoshihara M, Suyama M, Sun Y, Lemmers RJ, de Greef JC, Gennery A, Picco P, Kloeckener-Gruissem B, Güngör T, Reisli I, Picard C, Kebaili K, Roquelaure B, Iwai T, Kondo I, Kubota T, van Ostaijen-Ten Dam MM, van Tol MJ, Weemaes C, Francastel C, van der Maarel SM, Sasaki H.
|
| Nat Commun 6:7870. doi: 10.1038/ncomms8870. 2015
|
7 | CDCA7
|
| Identification of Cdca7 as a novel Notch transcriptional target involved in hematopoietic stem cell emergence.
|
| Guiu J, Bergen DJ, De Pater E, Islam AB, Ayllón V, Gama-Norton L, Ruiz-Herguido C, González J, López-Bigas N, Menendez P, Dzierzak E, Espinosa L, Bigas A.
|
| J Exp Med 211(12):2411-23. doi: 10.1084/jem.20131857. Epub 2014 Nov 10.
2014
|
8 | CDCA7
|
| The MYC-associated protein CDCA7 is phosphorylated by AKT to regulate MYC-dependent apoptosis and transformation.
|
| Gill RM, Gabor TV, Couzens AL, Scheid MP.
|
| Mol Cell Biol 33(3):498-513. doi: 10.1128/MCB.00276-12. Epub 2012 Nov 19.
2013
|
9 | CDCA7, CDCA7L, MAOA
|
| Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway.
|
| Ou XM, Chen K, Shih JC.
|
| Proc Natl Acad Sci U S A 103(29):10923-8. Epub 2006 Jul 7. 2006
|
10 | CDCA7
|
| JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity.
|
| Goto Y, Hayashi R, Muramatsu T, Ogawa H, Eguchi I, Oshida Y, Ohtani K, Yoshida K.
|
| Biochim Biophys Acta 1759(1-2):60-8. Epub 2006 Mar 24. 2006
|
11 | CDCA7
|
| The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo.
|
| Osthus RC, Karim B, Prescott JE, Smith BD, McDevitt M, Huso DL, Dang CV.
|
| Cancer Res 65(13):5620-7.
2005
|
12 | CDCA7
|
| A novel c-Myc-responsive gene, JPO1, participates in neoplastic transformation.
|
| Prescott JE, Osthus RC, Lee LA, Lewis BC, Shim H, Barrett JF, Guo Q, Hawkins AL, Griffin CA, Dang CV.
|
| J Biol Chem 276(51):48276-84. 2001
|